KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors -- a smart fighter that destroys cancer cells for days without tiring. Biomedical engineers have made this ...

Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit ...

National Institutes of Health cancer researcher Steven Rosenberg says political turmoil is starting to affect his work, ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

A new study has unveiled when chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow, arises in ...

“Structural variants like gene fusions are central to cancer diagnostics ... specimens across ten solid tumor types, comparing results using Arima’s technology to results from prior clinical ...

Researchers have validated a specific cluster of microRNAs (miRNAs) as reliable biomarkers for detecting malignant testicular ...

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...